ApprovalTrail

Company · Ottawa, Ontario, Canada

Csl Behring Canada Inc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
43
31 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
91

Drug products

Authorized products first.

NameDINStatus
ALBUREX - 25Status since Oct 200702274663Marketed
ALBUREX - 5Status since Jan 200802274655Marketed
ANDEMBRYStatus since Oct 202502559773Marketed
BERINERT 1500Status since May 201502436078Marketed
BERINERT 500Status since Dec 201402352575Marketed
BERIPLEX P/N 1000Status since Nov 201302410826Marketed
BERIPLEX P/N 500Status since Jul 201102359251Marketed
CORIFACT 1250Status since Apr 201402418746Marketed
CORIFACT 250Status since Apr 201402418738Marketed
HAEGARDAStatus since Jan 202002468069Marketed
HAEGARDAStatus since Jan 202002468077Marketed
HEMGENIXStatus since May 202602542560Marketed
HIZENTRAStatus since Sep 201702463059Marketed
HIZENTRAStatus since Sep 201702463067Marketed
HIZENTRAStatus since May 202102498251Marketed
HIZENTRAStatus since Feb 202402535424Marketed
HUMATE-PStatus since Sep 200702261219Marketed
HUMATE-PStatus since Oct 200702261227Marketed
HUMATE-PStatus since Oct 200702261235Marketed
PRIVIGENStatus since Jan 200902304619Marketed
RIASTAPStatus since Jan 201302393352Marketed
ANDEMBRYStatus since Aug 202502559765Approved
HIZENTRAStatus since Jul 202502370352Dormant
IDELVIONStatus since Jan 201602451336Approved
IDELVIONStatus since Jan 201602451344Approved
IDELVIONStatus since Jul 202302451352Dormant
IDELVIONStatus since Jan 201602451360Approved
IDELVIONStatus since Jun 201902489627Approved
ZEMAIRAStatus since Sep 201602457911Approved
ZEMAIRAStatus since Dec 201902494760Approved
ZEMAIRAStatus since Dec 201902494779Approved
AFSTYLAStatus since Sep 202402459531Cancelled Pre Market
AFSTYLAStatus since Sep 202402459558Cancelled Pre Market
AFSTYLAStatus since Sep 202402459566Cancelled Pre Market
AFSTYLAStatus since Sep 202402459574Cancelled Pre Market
AFSTYLAStatus since Sep 202402459582Cancelled Pre Market
AFSTYLAStatus since Sep 202402459590Cancelled Pre Market
AFSTYLAStatus since Sep 202402459604Cancelled Pre Market
SANDOGLOBULIN NF LIQUIDStatus since Apr 201002287994Cancelled Post Market
STREPTASEStatus since Feb 201202019000Cancelled Post Market
STREPTASEStatus since Feb 201202019019Cancelled Post Market
STREPTASEStatus since Feb 201202018993Cancelled Post Market
VIVAGLOBINStatus since Apr 201502282518Cancelled Post Market

Notices of Compliance

Newest first.

  • ANDEMBRYOctober 6, 2026 · NOC 38413 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAJune 29, 2026 · NOC 37803 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAApril 30, 2026 · NOC 37461 · Supplement to a New Drug Submission (SNDS)
  • RIASTAPMarch 31, 2026 · NOC 37228 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRAFebruary 11, 2026 · NOC 36890 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PFebruary 3, 2026 · NOC 36835 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500November 7, 2025 · NOC 36552 · Supplement to a New Drug Submission (SNDS)
  • CORIFACT 1250; CORIFACT 250August 15, 2025 · NOC 35853 · Supplement to a New Drug Submission (SNDS)
  • ANDEMBRYAugust 6, 2025 · NOC 35821 · New Drug Submission (NDS)
  • PRIVIGENJuly 25, 2025 · NOC 35773 · Supplement to a New Drug Submission (SNDS)
  • BERINERT 1500; BERINERT 500June 11, 2025 · NOC 35526 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PJune 3, 2025 · NOC 35472 · Supplement to a New Drug Submission (SNDS)
  • HEMGENIXMay 16, 2025 · NOC 35372 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAMarch 18, 2025 · NOC 35032 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRAJune 18, 2024 · NOC 33463 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRAJune 13, 2024 · NOC 33454 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONJanuary 9, 2024 · NOC 32519 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENNovember 8, 2023 · NOC 32051 · Supplement to a New Drug Submission (SNDS)
  • HEMGENIXOctober 23, 2023 · NOC 31923 · New Drug Submission (NDS)
  • PRIVIGENOctober 11, 2023 · NOC 31826 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRAMay 18, 2023 · NOC 30789 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRANovember 10, 2022 · NOC 29448 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAOctober 28, 2022 · NOC 29336 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENOctober 14, 2022 · NOC 29247 · Supplement to a New Drug Submission (SNDS)
  • HAEGARDAApril 13, 2022 · NOC 27986 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENMay 12, 2021 · NOC 25847 · Supplement to a New Drug Submission (SNDS)
  • HAEGARDAMarch 30, 2021 · NOC 25550 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRADecember 29, 2020 · NOC 24901 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONSeptember 22, 2020 · NOC 24278 · Supplement to a New Drug Submission (SNDS)
  • AFSTYLAMay 8, 2020 · NOC 23582 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAApril 22, 2020 · NOC 23501 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONApril 15, 2020 · NOC 23458 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRAApril 1, 2020 · NOC 23408 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRADecember 16, 2019 · NOC 23033 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500October 23, 2019 · NOC 22830 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500July 19, 2019 · NOC 22445 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONJune 18, 2019 · NOC 22302 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENMay 27, 2019 · NOC 22206 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENMay 15, 2019 · NOC 22156 · Supplement to a New Drug Submission (SNDS)
  • HAEGARDAOctober 26, 2018 · NOC 21464 · Supplement to a New Drug Submission (SNDS)
  • AFSTYLAOctober 16, 2018 · NOC 21420 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRASeptember 27, 2018 · NOC 21379 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAJuly 12, 2018 · NOC 21067 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONMay 18, 2018 · NOC 20882 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENApril 16, 2018 · NOC 20744 · Supplement to a New Drug Submission (SNDS)
  • CORIFACT 1250; CORIFACT 250January 19, 2018 · NOC 20389 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500September 25, 2017 · NOC 19845 · Supplement to a New Drug Submission (SNDS)
  • BERINERT 1500; BERINERT 500September 18, 2017 · NOC 19809 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PSeptember 15, 2017 · NOC 19801 · Supplement to a New Drug Submission (SNDS)
  • BERINERT 1500; BERINERT 500September 12, 2017 · NOC 19812 · Supplement to a New Drug Submission (SNDS)
  • HAEGARDASeptember 1, 2017 · NOC 19746 · New Drug Submission (NDS)
  • RIASTAPSeptember 1, 2017 · NOC 19749 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRAApril 13, 2017 · NOC 19160 · Supplement to a New Drug Submission (SNDS)
  • BERINERT 1500; BERINERT 500March 31, 2017 · NOC 19110 · Supplement to a New Drug Submission (SNDS)
  • AFSTYLADecember 12, 2016 · NOC 18755 · New Drug Submission (NDS)
  • PRIVIGENNovember 8, 2016 · NOC 18639 · Supplement to a New Drug Submission (SNDS)
  • ZEMAIRASeptember 21, 2016 · NOC 18497 · New Drug Submission (NDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500September 19, 2016 · NOC 18490 · Supplement to a New Drug Submission (SNDS)
  • RIASTAPFebruary 5, 2016 · NOC 17747 · Supplement to a New Drug Submission (SNDS)
  • IDELVIONJanuary 26, 2016 · NOC 17715 · New Drug Submission (NDS)
  • BERINERT 500April 17, 2015 · NOC 16800 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 1000; BERIPLEX P/N 500April 2, 2015 · NOC 16759 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENJanuary 2, 2015 · NOC 16480 · Supplement to a New Drug Submission (SNDS)
  • BERINERT 1500; BERINERT 500December 23, 2014 · NOC 16470 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRADecember 23, 2014 · NOC 16471 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENMay 23, 2014 · NOC 15625 · Supplement to a New Drug Submission (SNDS)
  • CORIFACT 250; CORIFACT 1250December 24, 2013 · NOC 15055 · New Drug Submission (NDS)
  • BERINERTSeptember 11, 2013 · NOC 14724 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/N 500; BERIPLEX P/N 1000August 14, 2013 · NOC 14645 · Supplement to a New Drug Submission (SNDS)
  • RIASTAPSeptember 13, 2012 · NOC 13648 · New Drug Submission (NDS)
  • BERINERTFebruary 21, 2012 · NOC 13048 · Supplement to a New Drug Submission (SNDS)
  • HIZENTRA (IMMUNE GLOBULIN SUBCUTANEOUS HUMAN)July 13, 2011 · NOC 12513 · New Drug Submission (NDS)
  • PRIVIGENMay 27, 2011 · NOC 12369 · Supplement to a New Drug Submission (SNDS)
  • CYTOGAMMarch 9, 2011 · NOC 12139 · Supplement to a New Drug Submission (SNDS)
  • BERIPLEX P/NNovember 5, 2010 · NOC 11849 · New Drug Submission (NDS)
  • BERINERTMay 31, 2010 · NOC 11459 · New Drug Submission (NDS)
  • PRIVIGENOctober 14, 2009 · NOC 10663 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PSeptember 14, 2009 · NOC 10583 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENJuly 10, 2009 · NOC 10373 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PJanuary 8, 2009 · NOC 9985 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENJanuary 6, 2009 · NOC 9984 · Supplement to a New Drug Submission (SNDS)
  • PRIVIGENJanuary 9, 2008 · NOC 9282 · New Drug Submission (NDS)
  • VIVAGLOBINDecember 7, 2007 · NOC 9232 · Supplement to a New Drug Submission (SNDS)
  • CYTOGAMOctober 9, 2007 · NOC 9076 · Supplement to a New Drug Submission (SNDS)
  • HUMATE-PSeptember 26, 2007 · NOC 9062 · Supplement to a New Drug Submission (SNDS)
  • MONONINEJune 22, 2007 · NOC 8859 · New Drug Submission (NDS)
  • VIVAGLOBINJune 20, 2007 · NOC 8860 · New Drug Submission (NDS)
  • CYTOGAMMay 8, 2007 · NOC 8768 · New Drug Submission (NDS)
  • STREPTASEMarch 30, 2007 · NOC 8682 · New Drug Submission (NDS)
  • SANDOGLOBULIN NF LIQUIDMarch 30, 2007 · NOC 8683 · New Drug Submission (NDS)
  • HUMATE-PMarch 26, 2007 · NOC 8669 · New Drug Submission (NDS)

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.